Concentra Group Holdings Parent Inc(CON) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 23.41 | EPS (ttm) | 1.52 | Insider Own | 9.57% | Shs Outstand | 127.5M | Perf Week | 5.14% |
| Market Cap | 4.54B | Forward P/E | 19.37 | EPS next Y | 11.52% | Insider Trans | -4.09% | Shs Float | 115.3M | Perf Month | 0.54% |
| Enterprise Value | 6.56B | PEG | 1.44 | EPS next Q | 0.44 | Inst Own | 87.93% | Short Float | 2.43% | Perf Quarter | 26.54% |
| Income | 0.20B | P/S | 1.99 | EPS this Y | 20.36% | Inst Trans | 1.66% | Short Ratio | 3.04 | Perf Half Y | 57.47% |
| Sales | 2.29B | P/B | 9.52 | EPS next 5Y | 13.44% | ROA | 6.71% | Short Interest | 2.80M | Perf YTD | 81% |
| Book/sh | 3.74 | P/C | 28.74 | EPS past 3/5Y | -0.96% -6.16% | ROE | 47.89% | 52W High | -1.19% ($36.05) | Perf Year | 67.78% |
| Cash/sh | 1.24 | P/FCF | 16.99 | Sales past 3/5Y | 7.85% 5.72% | ROIC | 7.79% | 52W Low | 92.07% ($18.55) | Perf 3Y | - |
| Dividend Est. | $0.13 (0.36%) | EV/EBITDA | 14.19 | EPS Y/Y TTM | 31.92% | Gross Margin | 25.83% | Volatility(W/M) | 2.47% 2.24% | Perf 5Y | - |
| Dividend TTM | 0.25 | EV/Sales | 2.87 | Sales Y/Y TTM | 14.02% | Oper. Margin | 16.71% | ATR (14) | 0.87 | Perf 10Y | - |
| Dividend Ex-Date | 2026/8/20 | Quick Ratio | 1.38 | EPS Q/Q | 45.65% | Profit Margin | 8.53% | RSI (14) | 64.35 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.38 | Sales Q/Q | 10.03% | SMA20 | 2.85% ($34.63) | Beta | 0.59 | Target Price | $41 |
| Payout | 19.54% | Debt/Eq | 4.49 | Earnings | 2026/8/6 | SMA50 | 7.44% ($33.15) | Rel Volume | 0.9 | Prev Close | $35.81 |
| Employees | 13133 | LT Debt/Eq | 4.28 | EPS/Sales Surpr. | 23.34% 2.41% | SMA200 | 38.95% ($25.64) | Avg Volume(3M) | 0.92M | Price | $35.62 |
| IPO | 2024/7/25 | Option/Short | Yes/Yes | Trades | 9819 | Volume | 830,059 | Change | -0.53% |
Company
CON is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A US healthcare services company that operates occupational health clinics. It runs a network of occupational health clinics that provide workers' compensation injury care and corporate health screening and preventive services, and is characterized by stable demand from its corporate and insurance client base. It is a leading company in the occupational health sector.
Over the past 1 year, on the higher side
1% below its 1-year high.
CON makes money exceptionally well
16.71% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +20.4% this year.
Tap to view numbers
The price looks about right
Trading at 23.4 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Tap to view numbers
The dividend is on the small side
Pays 0.36% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 87.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
It ranks #4 in the industry
Based on market cap of $5B.
FAQ
What kind of company is CON?
CON belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of CON?
The market cap of CON is approximately $4.5B, ranking 1,456 within its sector.
Does CON pay dividends?
CON has a dividend yield of approximately 0.36%, with an annual dividend of $0.13.
What is the P/E ratio of CON?
CON has a P/E ratio of approximately 23.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CON?
CON has recorded a 52-week high of $36.05 and a low of $18.55.